Furthermore, eGFRcys has a greater association vs eGFRcr with future risk of cardiovascular disease (CVD) and death.5,6 However, the recommendation to conduct concordance testing for CKD with cystatin C is rarely implemented.7 This evidence concerns the gene CST3 and chronic kidney disease.